REVVITY, INC (RVTY) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-07-05..
Gross margin
Overview →Financial period ending 2026-07-05; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-07-05. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 2.91B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-07-05 | (m) | $2.91B | (m) | (m) |
| 2026-04-05 | (m) | $2.90B | (m) | (m) |
| 2025-12-28 | (m) | $2.86B | (m) | (m) |
| 2025-09-28 | (m) | $2.81B | (m) | (m) |
| 2025-06-29 | (m) | $2.80B | (m) | (m) |
| 2025-03-30 | (m) | $2.77B | (m) | (m) |
| 2024-12-29 | (m) | $2.76B | (m) | (m) |
| 2024-09-29 | (m) | $2.72B | (m) | (m) |
| 2024-06-30 | (m) | $2.71B | (m) | (m) |
| 2024-03-31 | (m) | $2.73B | (m) | (m) |
| 2023-12-31 | (m) | $2.75B | (m) | (m) |
| 2023-10-01 | (m) | $2.80B | (m) | (m) |
| 2023-07-02 | (m) | $2.84B | (m) | (m) |
| 2023-04-02 | (m) | $3.02B | (m) | (m) |
| 2023-01-01 | $1.99B | $3.31B | (m) | 60.08% |
| 2022-10-02 | (m) | $4.84B | (m) | (m) |
| 2022-07-03 | (m) | $5.02B | (m) | (m) |
| 2022-04-03 | (m) | $5.02B | (m) | (m) |
| 2022-01-02 | (m) | $5.07B | (m) | (m) |
| 2021-10-03 | (m) | $5.06B | (m) | (m) |
| 2021-07-04 | (m) | $4.85B | (m) | (m) |
| 2021-04-04 | (m) | $4.44B | (m) | (m) |
| 2021-01-03 | $2.11B | $3.78B | (m) | 55.78% |
| 2020-10-04 | (m) | $3.23B | (m) | (m) |
| 2020-07-05 | (m) | $2.98B | (m) | (m) |
| 2020-04-05 | (m) | $2.89B | (m) | (m) |
| 2019-12-29 | $1.40B | $2.88B | (m) | 48.41% |
| 2019-09-29 | (m) | $2.83B | $1.46B | (m) |
| 2019-06-30 | (m) | $2.80B | $1.44B | (m) |
| 2019-03-31 | (m) | $2.78B | $1.43B | (m) |
| 2018-12-30 | $1.34B | $2.78B | $1.44B | 48.27% |
| 2018-09-30 | (m) | $2.66B | (m) | (m) |
| 2018-07-01 | (m) | $2.54B | (m) | (m) |
| 2018-04-01 | (m) | $2.39B | (m) | (m) |
| 2017-12-31 | $1.07B | $2.26B | (m) | 47.54% |
| 2017-10-01 | (m) | $2.18B | (m) | (m) |
| 2017-07-02 | (m) | $2.14B | (m) | (m) |
| 2017-04-02 | (m) | $2.13B | (m) | (m) |
| 2017-01-01 | $1.01B | $2.12B | (m) | 47.90% |
| 2016-10-02 | (m) | $2.27B | (m) | (m) |
| 2016-07-03 | (m) | $2.28B | (m) | (m) |
| 2016-04-03 | (m) | $2.27B | (m) | (m) |
| 2016-01-03 | $1.02B | $2.26B | (m) | 45.28% |
| 2015-10-04 | (m) | $2.26B | (m) | (m) |
| 2015-06-28 | (m) | $2.24B | (m) | (m) |
| 2015-03-29 | (m) | $2.23B | (m) | (m) |
| 2014-12-28 | $1.00B | $2.24B | (m) | 44.90% |
| 2014-09-28 | (m) | $2.23B | (m) | (m) |
| 2014-06-29 | (m) | $2.21B | (m) | (m) |
| 2014-03-30 | (m) | $2.19B | (m) | (m) |
| 2013-12-29 | $976.97M | $2.17B | (m) | 45.10% |
| 2013-09-29 | (m) | $2.15B | (m) | (m) |
| 2013-06-30 | (m) | $2.13B | (m) | (m) |
| 2013-03-31 | (m) | $2.11B | (m) | (m) |
| 2012-12-30 | $963.21M | $2.12B | (m) | 45.54% |
| 2012-09-30 | (m) | $2.08B | (m) | (m) |
| 2012-07-01 | (m) | $2.03B | (m) | (m) |
| 2012-04-01 | (m) | (m) | (m) | (m) |
| 2012-01-01 | $850.58M | $1.92B | (m) | 44.27% |
| 2011-10-02 | (m) | $1.85B | $1.03B | (m) |
| 2011-07-03 | (m) | $1.82B | $1.01B | (m) |
| 2011-04-03 | (m) | $1.76B | $975.00M | (m) |
| 2011-01-02 | (m) | $1.70B | $945.72M | (m) |
| 2010-10-03 | (m) | (m) | (m) | (m) |
| 2010-07-04 | (m) | (m) | (m) | (m) |
| 2010-04-04 | (m) | (m) | (m) | (m) |
| 2010-01-03 | (m) | $1.55B | $851.78M | (m) |
| 2009-10-04 | (m) | (m) | (m) | (m) |
| 2009-07-05 | (m) | (m) | (m) | (m) |
| 2008-12-28 | (m) | $1.66B | $925.97M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |